PREVENT Equations Reclassify Half of U.S. Adults to Lower ASCVD Risk
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- Use of the Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations instead of the 2013 recommended pooled cohort equations for estimating the 10-year risk for atherosclerotic cardiovascular disease could result in a considerable decrease in the number of adults receiving or recommended for preventive treatment with statin or antihypertensive therapy, according to a study published online July 29 in the Journal of the American Medical Association.
James A. Diao, M.D., from Harvard Medical School in Boston, and colleagues estimated changes in risk categorization, treatment eligibility, or clinical outcomes when applying PREVENT equations to existing American College of Cardiology (ACC) and American Heart Association (AHA) guidelines. Data were included for a sample of 7,765 U.S. adults aged 30 to 79 years who participated in the National Health and Nutrition Examination Surveys from 2011 to March 2020.
The researchers estimated that using PREVENT equations would reclassify about half (53 percent) of U.S. adults to lower ACC and AHA risk categories and very few (0.41 percent) to higher risk categories. There would be an estimated decrease in the number of U.S. adults receiving or recommended for preventive treatment of 14.3 million for statin therapy and 2.62 million for antihypertensive therapy. These decreases could result in 107,000 additional occurrences of myocardial infarction or stroke over 10 years. The changes in eligibility would affect twice as many men as women and a greater proportion of Black than White adults.
"The magnitude of these projected changes warrants careful reconsideration of current treatment thresholds using decision-analytic or cost-effectiveness frameworks," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Mortality, Sudden Cardiac Death Higher for Male Professional Bodybuilders
THURSDAY, May 22, 2025 -- The risks for death and sudden cardiac death (SCD) are higher for male bodybuilders than amateurs, according to a study published online May 20 in the...
Risk of Poor Cardiovascular Outcomes Up in Aging Patients With Down Syndrome
THURSDAY, May 15, 2025 -- Individuals with Down syndrome are at increased risk of poor cardiovascular outcomes, according to a study published online May 7 in the Journal of...
CVD Mortality Higher in Women Than Men With Immune-Mediated Inflammatory Diseases
TUESDAY, May 13, 2025 -- For patients with immune-mediated inflammatory diseases (IMID), cardiovascular disease (CVD) mortality decreased from 1999 to 2020, but sex disparities...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.